overview comprises of simple headache pill to sophisticated antibiotics 15.7% growth rate last year...
TRANSCRIPT
![Page 1: Overview Comprises of simple headache pill to sophisticated antibiotics 15.7% growth rate last year – Expected to touch US$74 billion sales by 2020 3](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649dce5503460f94ac1c4a/html5/thumbnails/1.jpg)
![Page 2: Overview Comprises of simple headache pill to sophisticated antibiotics 15.7% growth rate last year – Expected to touch US$74 billion sales by 2020 3](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649dce5503460f94ac1c4a/html5/thumbnails/2.jpg)
Overview
• Comprises of simple headache pill to sophisticated antibiotics
• 15.7% growth rate last year – Expected to touch US$74 billion sales by 2020
• 3rd largest in terms of Production volume and 4th in terms of Consumption value
• Cost of innovation is high• Indian companies manufacture
Generic Drugs Intermediaries Bulk drugs or APIs
![Page 3: Overview Comprises of simple headache pill to sophisticated antibiotics 15.7% growth rate last year – Expected to touch US$74 billion sales by 2020 3](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649dce5503460f94ac1c4a/html5/thumbnails/3.jpg)
![Page 4: Overview Comprises of simple headache pill to sophisticated antibiotics 15.7% growth rate last year – Expected to touch US$74 billion sales by 2020 3](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649dce5503460f94ac1c4a/html5/thumbnails/4.jpg)
Major PlayersRevenue in 2012 (Rs. Crore)
Ranbaxy Labs 7,686.59
Cipla 6,977.50
Dr Reddys Labs 6,686.30
Lupin 5,364.37
Aurobindo Pharm 4,284.63
Cadila Health 3,152.20
Jubilant Life 2,641.07
Wockhardt 2,560.16
Ipca Labs 2,352.59
GlaxoSmithKline 2,345.88
![Page 5: Overview Comprises of simple headache pill to sophisticated antibiotics 15.7% growth rate last year – Expected to touch US$74 billion sales by 2020 3](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649dce5503460f94ac1c4a/html5/thumbnails/5.jpg)
Drug development process
Research & development Screening Tests on Animals
Clinical trialsFDA approvalDevelopment of
production process
![Page 6: Overview Comprises of simple headache pill to sophisticated antibiotics 15.7% growth rate last year – Expected to touch US$74 billion sales by 2020 3](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649dce5503460f94ac1c4a/html5/thumbnails/6.jpg)
Value chain in Pharma industry
![Page 7: Overview Comprises of simple headache pill to sophisticated antibiotics 15.7% growth rate last year – Expected to touch US$74 billion sales by 2020 3](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649dce5503460f94ac1c4a/html5/thumbnails/7.jpg)
Why is Forecasting important in Pharma?
• Projections of the sales of new drugs, especially of blockbuster drugs, have almost always been too high. Investors have been burned so many times with this game that it is difficult to understand why they continue to play it.
Company Drug name Estimated ActualMerck Blocarden 500-1000 15Sterling Amrinone(Oral) 500 0Smith Kline Tagamet 200 1000Searle Aspartme 0 585
Peak sales(in mn US$)
![Page 8: Overview Comprises of simple headache pill to sophisticated antibiotics 15.7% growth rate last year – Expected to touch US$74 billion sales by 2020 3](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649dce5503460f94ac1c4a/html5/thumbnails/8.jpg)
Forecast Links to Other Functional Areas
![Page 9: Overview Comprises of simple headache pill to sophisticated antibiotics 15.7% growth rate last year – Expected to touch US$74 billion sales by 2020 3](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649dce5503460f94ac1c4a/html5/thumbnails/9.jpg)
Forecasting Methodology
• Data Collection, Analysis and product segmentation• Managerial participation for segment validation• Generation of time horizons and set of forecasting
policies• Identification of set of suitable sales forecasting
algorithms –time frame, behavior & the possible existence of pattern
• Development of User interface for algorithms • Solution Testing and roll out plan • Implementation
![Page 10: Overview Comprises of simple headache pill to sophisticated antibiotics 15.7% growth rate last year – Expected to touch US$74 billion sales by 2020 3](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649dce5503460f94ac1c4a/html5/thumbnails/10.jpg)
Production ProcessGranulation
• Process in which primary powder particles are made to adhere to form larger, multiparticle entities called granules.
Compression
• It a key unit operation in order to develop solid oral dosage forms such as tablets.
Coating
• Sugar coating. It is done to prevent bitter taste, to improve stability (prevent oxidation of active drug ingredients).
Packaging
• It is done in order to keep the end products free from contamination, hinder microbial growth, and ensure product safety
![Page 11: Overview Comprises of simple headache pill to sophisticated antibiotics 15.7% growth rate last year – Expected to touch US$74 billion sales by 2020 3](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649dce5503460f94ac1c4a/html5/thumbnails/11.jpg)
Why ERP?
Track InventoryMake sure we got what the Wholesaler wantsMake sure we don't manufacture too much
Product Orders are sent via EDIOrder ConfirmationDocumentation
Manufacture of Controlled ProductsProduct Development Area
Operator Verification & QualificationFDA Regulations for Training
ERP Modules
SCM
Order Mgmt.
Pharma Specific
HR
![Page 12: Overview Comprises of simple headache pill to sophisticated antibiotics 15.7% growth rate last year – Expected to touch US$74 billion sales by 2020 3](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649dce5503460f94ac1c4a/html5/thumbnails/12.jpg)
Benefits of ERP
Inventories of Reagents
Shelf Life
Outsourced Integration
Operational excellence reducing waste, running more efficiently and maximizing utilization
Enhanced and market aligned decision making
Compliance with evolving USDA, FDA and ICH and other regulations
Consistently producing the highest-quality products.
Manufacturing agility enabling better reaction to opportunities and obstacles
Managing profitability for greater business growth
Competitive advantages
![Page 13: Overview Comprises of simple headache pill to sophisticated antibiotics 15.7% growth rate last year – Expected to touch US$74 billion sales by 2020 3](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649dce5503460f94ac1c4a/html5/thumbnails/13.jpg)
Functions of Packaging
Containment- Not to leak, nor allow diffusion and permeation- Strong enough to hold the contents during handling
Protection- Light- Moisture- Oxygen- Biological contamination- Mechanical damage- Counterfeiting
![Page 14: Overview Comprises of simple headache pill to sophisticated antibiotics 15.7% growth rate last year – Expected to touch US$74 billion sales by 2020 3](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649dce5503460f94ac1c4a/html5/thumbnails/14.jpg)
Material characteristics - It must preserve the physical properties of all dosage forms and protect them �against damage or breakage.
- It must not alter the identity of the product.�
- It must preserve the characteristics properties of the product to comply �specifications.
- It must protect product against undesirable or adulterating chemical, biological or physical entities
![Page 15: Overview Comprises of simple headache pill to sophisticated antibiotics 15.7% growth rate last year – Expected to touch US$74 billion sales by 2020 3](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649dce5503460f94ac1c4a/html5/thumbnails/15.jpg)
Importance of quality in Pharma
? MEDICINE QUALITY
Manufacturing process
Packaging Transportation Storage
condition
§ Lack of therapeutic effect:§ Prolonged illness§Death
§ Toxic and adverse reaction
§ Waste of limited financial resources
§ Loss of credibility
![Page 16: Overview Comprises of simple headache pill to sophisticated antibiotics 15.7% growth rate last year – Expected to touch US$74 billion sales by 2020 3](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649dce5503460f94ac1c4a/html5/thumbnails/16.jpg)
Determinants of quality of medicines
Identity: Active ingredient Purity: Not contaminated with potentially harmful
substances Potency: Usually 90–110% of the labeled amount Uniformity: Consistency of color, shape, size Bioavailability: Interchangeable products? Stability: Ensuring medicine activity for stated period
![Page 17: Overview Comprises of simple headache pill to sophisticated antibiotics 15.7% growth rate last year – Expected to touch US$74 billion sales by 2020 3](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649dce5503460f94ac1c4a/html5/thumbnails/17.jpg)
How is quality of medicine assured?
Product selection Long shelf-life Acceptable stability Acceptable bioavailability
Selection of appropriate suppliers Supplier pre-qualification Request samples from new suppliers Request specific reports and data for certain medicines (e.g.,
bioavailability and stability studies) Collect and maintain information on supplier performance
Product certification GMP certificate of manufacturer Product/batch certification (COA) Random local testing
![Page 18: Overview Comprises of simple headache pill to sophisticated antibiotics 15.7% growth rate last year – Expected to touch US$74 billion sales by 2020 3](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649dce5503460f94ac1c4a/html5/thumbnails/18.jpg)
Key Challenges in Pharma Industry
Pharma Company
Wholesalers/Patients
Raw material suppliers
Contract LabsAPI suppliers
Contract manufacturers
CMO’s
• Lack of Visibility to manufacturing schedules
• No collaboration on forecasts
• Quality Control• Short Shelf life• Increasing prices
• No collaboration• Excess inventory• Increasing
inventory
• No visibility to labs• Unexpected delays• Increasing
regulations
• Fluctuating demands, seasonality, epidemics
• Competitive pressures• Shortening delivery lead
times• Excess inventory• Limited shelf life
![Page 19: Overview Comprises of simple headache pill to sophisticated antibiotics 15.7% growth rate last year – Expected to touch US$74 billion sales by 2020 3](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649dce5503460f94ac1c4a/html5/thumbnails/19.jpg)
• With increased outsourcing in the pharmaceutical industry managing inventory is becoming very important
• The pharmaceutical industry is undergoing major change many ‘blockbuster’ patents are expiring and generic competition is increasing and this is leading to higher pressure on prices
• Biopharma companies traditionally have long supply lead times, starting with raw material sourcing and continuing through API/drug substance production, drug product production, and packaging/labeling/distribution- This is leading to high amounts of inventory at each stage of the process
• By reducing inventory, companies can ensure:- higher service levels with reduced inventory- simplified planning processes- reduced obsolescence- significant liberation of cash
Inventory Management in Pharma Industry
![Page 20: Overview Comprises of simple headache pill to sophisticated antibiotics 15.7% growth rate last year – Expected to touch US$74 billion sales by 2020 3](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649dce5503460f94ac1c4a/html5/thumbnails/20.jpg)
VMI is one of the methods by which inventory can be reduced
![Page 21: Overview Comprises of simple headache pill to sophisticated antibiotics 15.7% growth rate last year – Expected to touch US$74 billion sales by 2020 3](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649dce5503460f94ac1c4a/html5/thumbnails/21.jpg)
Lean manufacturing is being adopted in Pharma industry to reduce costs
• Globally large companies like Merck, Novartis are adopting lean manufacturing techniques to improve profitability
• Merck has developed the Merck production system (MPS) based on lean principles, the core philosophy of MPS is:
Waste elimination
• Reduction in change over times
• Reduction in inventory
• Reduce wastage of Overproduction
Demand pull system
• Network of automated pull signals was created
• Merck moved from a rigid monthly schedule to a flexible one driven by customer demand
Continuous manufacturing
• Based on value stream mapping wastages were identified in the processes
• Reduction in lead times
![Page 22: Overview Comprises of simple headache pill to sophisticated antibiotics 15.7% growth rate last year – Expected to touch US$74 billion sales by 2020 3](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649dce5503460f94ac1c4a/html5/thumbnails/22.jpg)
Results of Merck’s lean production System
• 50% overall reductions in cycle time• 65% reduction in product testing time• 30% reductions in inventory for some product• 10 to 20% operating expense reductions• 50% reduction in changeover time on some
packaging lines
![Page 23: Overview Comprises of simple headache pill to sophisticated antibiotics 15.7% growth rate last year – Expected to touch US$74 billion sales by 2020 3](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649dce5503460f94ac1c4a/html5/thumbnails/23.jpg)
Large company
• Ex : Cipla, Ranbaxy etc.• For generic products – own manufacturing facility
and distribution network• For expert products – contracts with companies• Product types – capsules, liquid, cosmetic
products• Quarterly plan• Primary aim – Downsizing the competition• Pump in more than the market demand
![Page 24: Overview Comprises of simple headache pill to sophisticated antibiotics 15.7% growth rate last year – Expected to touch US$74 billion sales by 2020 3](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649dce5503460f94ac1c4a/html5/thumbnails/24.jpg)
Small/medium sized company
• Ex : Audax pharma, Gems etc.• Contracts with factories for manufacturing• Manufacturing process – MTO• Gems – Outsources to factories in Faridabad• Order selection done by factories on basis of batch
volume – cost saving• Vague inventory – independent of market share• Transportation – By road ; C form mandatory
![Page 25: Overview Comprises of simple headache pill to sophisticated antibiotics 15.7% growth rate last year – Expected to touch US$74 billion sales by 2020 3](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649dce5503460f94ac1c4a/html5/thumbnails/25.jpg)
Process flowOrder given to factories
Factories place order for packaging based on the order received
Manufacturing starts once raw material for packaging is received
Testing and quality check
Packaging and Distribution to wholesalers